-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NW9fLViLquqPI/CPI1QfPReDCvIoU2h7JlWai+DdizLzW3zyu3nRMfIe1v4phTKM XMtAGhkTUeQwPr2ivSj9rA== 0000933745-06-000011.txt : 20060331 0000933745-06-000011.hdr.sgml : 20060331 20060331122104 ACCESSION NUMBER: 0000933745-06-000011 CONFORMED SUBMISSION TYPE: POS AM PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060331 DATE AS OF CHANGE: 20060331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MIRAVANT MEDICAL TECHNOLOGIES CENTRAL INDEX KEY: 0000933745 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770222872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: POS AM SEC ACT: 1933 Act SEC FILE NUMBER: 333-93385 FILM NUMBER: 06726662 BUSINESS ADDRESS: STREET 1: 336 BOLLAY DRIVE CITY: SANTA BARBARA STATE: CA ZIP: 93117 BUSINESS PHONE: 8056859880 MAIL ADDRESS: STREET 1: 336 BOLLAY DRIVE CITY: SANTA BARBARA STATE: CA ZIP: 93117 FORMER COMPANY: FORMER CONFORMED NAME: PDT INC /DE/ DATE OF NAME CHANGE: 19941214 POS AM 1 posamendno1_93385.htm POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 333-93385 Post Effective Amendment No. 1 to Form S-8 333-93385
            As filed with the Securities and Exchange Commission on March 31, 2006
                                                     Registration No. 333-93385

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________
 
POST-EFFECTIVE AMENDMENT NO. 1 
TO FORM S-8
REGISTRATION STATEMENT
 
UNDER
THE SECURITIES ACT OF 1933
___________
MIRAVANT MEDICAL TECHNOLOGIES
(Exact name of registrant as specified in its charter)

Delaware
(State or Other Jurisdiction of
Incorporation or Organization)

Miravant Medical Technologies 1996 Stock Compensation Plan
Miravant Medical Technologies 1992 Stock Plan
Non-Employee Directors’ Stock Option Plan
Employment Agreement Stock Options
(Full title of the plan)
77-0222872
(I.R.S. Employer
Identification Number)
     
7408 Hollister Avenue
Santa Barbara, California 93117
(805) 685-9880
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
John M. Philpott
Chief Financial Officer
Miravant Medical Technologies
7408 Hollister Avenue
Santa Barbara, California 93117
(805) 685-9880
(Name, address, including zip code, and telephone number, including area code, of agent for service)
 
________
Copies to:
JOHN T. SHERIDAN, Esq.
Wilson Sonsini Goodrich & Rosati, a Professional Corporation
650 Page Mill Road
Palo Alto, CA 94304-1050
(650) 493-9300
                         
 



EXPLANATORY NOTE

This Post-Effective Amendment No. 1 to Form S-8 Registration Statement  (Reg. No. 333-93385) is being filed by the registrant to remove from registration any securities that remain sold thereunder as of the date of the filing of this post-effective amendment. The registrant hereby removes such securities from registration and the registration is hereby terminated. The registrant is also concurrently filing a Form 15 with the SEC to terminate the registration of its shares of common stock under the Securities Exchange Act of 1934, as amended.
-----------




SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Santa Barbara, State of California, on March 31, 2006.

 
Miravant Medical Technologies
 
 
By:
 
/s/ David E. Mai
David E. Mai
Principal Executive Officer

 
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

Name
Title
   
 
/s/ David E. Mai
David E. Mai
 
Director and President (principal executive officer)
 
/s/ John M. Philpott
John M. Philpott
 
Chief Financial Officer (principal financial officer and principal accounting officer)
 
______*_______
Nuno Brandolini
 
 
Director
 
______*_______
Michael Khoury  
 
 
Director
 
______*_______
Kevin R. McCarthy
 
 
Director
 
______*_______
Robert J. Sutcliffe  
 
 
Director


By: /s/ John M. Philpott
John M. Philpott
Attorney-in-Fact pursuant to a Power of Attorney attached hereto




Power of Attorney

Know All Men By These Presents, that the person whose signature appears below hereby constitutes and appoints David E. Mai and John M. Philpott, or either of them, his attorneys-in-fact and agents, each with full power of substitution for him and in his name, place and stead, in any and all capacities, to sign any post-effective amendments to the registration statements indicated on Schedule A hereto, and to file the same with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto each of said attorneys-in-fact and agents full power and authority to do so and perform each and every act and thing requisite and necessary to be done in connection with such registration statements, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that either of said attorneys-in-fact and agents, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Name
Title
Date
     
 
/s/ David E. Mai
David E. Mai
 
Director and President (principal executive officer)
 
March 31, 2006
 
/s/ John M. Philpott
John M. Philpott
 
Chief Financial Officer (principal financial officer and principal accounting officer)
 
March 31, 2006
 
/s/ Nuno Brandolini
Nuno Brandolini
 
Director
 
March 31, 2006
 
/s/ Michael Khoury
Michael Khoury
 
Director
 
March 31, 2006
 
/s/ Kevin R. McCarthy
Kevin R. McCarthy
 
Director
 
March 31, 2006
 
/s/ Robert J. Sutcliffe
Robert J. Sutcliffe
 
Director
 
March 31, 2006

 

Schedule A to Power of Attorney

SEC File Number
Form of Registration Statement
Dates Filed and Amended
333-39905
S-3
Filed 11/10/97; Amended 12/05/97
333-60251
S-3
Filed 07/30/98; Amended 12/14/98, 05/27/99
333-84003
S-3
Filed 07/29/99
333-71696
S-3
Filed 10/17/01; Amended 11/20/01, 04/09/02, 05/13/02, 05/31/02
333-29413
S-8
Filed 06/17/97
333-34953
S-8
Filed 09/04/97
333-93385
S-8
Filed 12/22/99
333-44728
S-8
Filed 08/29/00
333-117386
S-8
Filed 07/15/04
333-120963
S-2
Filed 12/03/04; Amended 01/04/05, 06/10/05
333-125746
S-2
Filed 06/10/05
033-87138
S-3 (Post-effective amendment to S-1)
Filed 06/25/96
     

-----END PRIVACY-ENHANCED MESSAGE-----